HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $993,391 | +10.3% | 26,005 | +4.2% | 0.18% | +12.2% |
Q2 2023 | $900,271 | -4.6% | 24,959 | +1.0% | 0.16% | -7.7% |
Q1 2023 | $943,828 | -47.3% | 24,714 | -21.5% | 0.17% | -47.7% |
Q4 2022 | $1,792,066 | +37.7% | 31,495 | -4.3% | 0.32% | +24.7% |
Q3 2022 | $1,301,000 | +4.5% | 32,913 | +16.3% | 0.26% | +8.8% |
Q2 2022 | $1,245,000 | -17.4% | 28,293 | -25.2% | 0.24% | -1.7% |
Q1 2022 | $1,508,000 | +4.6% | 37,820 | +5.5% | 0.24% | +13.6% |
Q4 2021 | $1,442,000 | -24.0% | 35,850 | -23.2% | 0.21% | -26.6% |
Q3 2021 | $1,898,000 | -9.3% | 46,669 | +1.3% | 0.29% | -5.8% |
Q2 2021 | $2,093,000 | +7.8% | 46,086 | -1.0% | 0.31% | +1.3% |
Q1 2021 | $1,942,000 | -3.7% | 46,574 | -1.4% | 0.30% | -8.7% |
Q4 2020 | $2,017,000 | +64.1% | 47,226 | +1.0% | 0.33% | +47.3% |
Q3 2020 | $1,229,000 | -2.6% | 46,750 | -0.7% | 0.23% | -5.0% |
Q2 2020 | $1,262,000 | +34.7% | 47,074 | -9.6% | 0.24% | +15.0% |
Q1 2020 | $937,000 | +2.0% | 52,073 | +0.5% | 0.21% | +31.0% |
Q4 2019 | $919,000 | +27.8% | 51,832 | +11.8% | 0.16% | +102.6% |
Q3 2019 | $719,000 | -9.4% | 46,353 | +0.2% | 0.08% | -4.9% |
Q2 2019 | $794,000 | -4.8% | 46,243 | -10.8% | 0.08% | -6.8% |
Q1 2019 | $834,000 | +10.0% | 51,827 | 0.0% | 0.09% | -2.2% |
Q4 2018 | $758,000 | -4.9% | 51,827 | +18.1% | 0.09% | +12.5% |
Q3 2018 | $797,000 | +25.7% | 43,876 | +16.8% | 0.08% | +21.2% |
Q2 2018 | $634,000 | -17.1% | 37,552 | -3.8% | 0.07% | -16.5% |
Q1 2018 | $765,000 | -2.2% | 39,040 | +1.2% | 0.08% | +2.6% |
Q4 2017 | $782,000 | +50.4% | 38,588 | +28.9% | 0.08% | +51.0% |
Q3 2017 | $520,000 | +36.5% | 29,945 | +0.9% | 0.05% | +27.5% |
Q2 2017 | $381,000 | -4.5% | 29,687 | -3.6% | 0.04% | -4.8% |
Q1 2017 | $399,000 | -32.8% | 30,786 | -48.8% | 0.04% | -33.3% |
Q4 2016 | $594,000 | – | 60,119 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |